Here are recent angel and venture finance transactions for science- and engineering-based companies reported by Xconomy.
Biomedical/Life Sciences
Meritage Pharma in San Diego, California. Specialty drug discovery and development. $2 million, equity.
XDx in Brisbane, California. Molecular diagnostics. $12.5 million, debt (from GE Capital)
Stromedix in Cambridge, Massachusetts. Specialty drug discovery and development. $2 million, debt.
RainDance Technologies in Lexington, Massachusetts. Genomic research tools. $37.5 million, series D equity.
Energy
Envia Systems in Newark, California. Cathodes for high-capacity lithium ion batteries. $17 million, series C equity.
Fulcrum BioEnergy in Pleasanton, California. Technology for converting municipal solid waste into ethanol. $75 million, series C equity.
Physical Sciences
Myriant Technologies in Quincy, Massachusetts. Biochemicals. $60 million, equity financing (from PTT Chemical Public Company, Thailand)
Xtalic in Marlborough, Massachusetts. Nanostructured alloy coatings for electronics components. $8 million, equity.
Engineering and Electronics
Liquid Piston in Bloomfield, Connecticut. Advanced internal combustion engines. $5 million, series B equity.
Liquid Robotics, in Sunnyvale, California. Maritime robotic vehicles. $18 million, equity.
Read more: Finance Friday: 21 January 2011
* * *
You must be logged in to post a comment.